Author:
Sylvester Richard J.,van der Meijden Adrian P.M.,Oosterlinck Wim,Hoeltl Wolfgang,Bono Aldo V.
Reference20 articles.
1. Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials;Sylvester;J Urol,2002
2. Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity;Bohle;J Urol,2003
3. Lamm DL, Steg A, Boccon-Gibod L, Morales A, Hanna Jr MG, Pagano F, et al. Complications of bacillus Calmette-Guerin immunotherapy: Review of 2602 patients and comparison of chemotherapy complications. Prog Clin Biol Res 1989;335–55.
4. A randomized trial of intravesical doxorubicin and immunotherapy with bacillus Calmette-Guérin for transitional cell carcinoma of the bladder;Lamm;N Eng J Med,1991
5. Intravesical instillation of epirubicin, bacillus Calmette-Guerin, and bacillus Calmette-Guerin plus isoniazid for intermediate and high risk Ta, T1 papillary carcinoma of the bladder. A European Organization for Research and Treatment of Cancer GU Group randomized phase III trial;Van der Meijden;J Urol,2001
Cited by
66 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献